Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 76.79K 71.48K 65.65K 123K 8.38M 125K 850K 332K 4.14M 328K 321K 14.3M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 216M 201M 185M 347M 23.57B 351M 2.39B 934M 11.64B 922M 903M 40.22B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+0.04%+4.47%+48.27%+163.34% 1,067B
+1.79%+7.82%+61.39%+54.45% 635B
-0.17%+2.30%+37.50%+74.14% 458B
+1.41%+8.56%+38.18%+32.17% 347B
+1.28%+4.40%+37.69%+41.62% 295B
+1.72%+4.10%+19.44%+20.45% 262B
+1.84%-0.46%-27.63%-38.65% 216B
+0.14%+3.41%+24.99%+59.53% 203B
+1.61%-1.34%+16.28%+71.78% 161B
Average +1.08%+1.19%+28.46%+53.20% 364.35B
Weighted average by Cap. +0.95%+1.95%+38.10%+78.72%

Financials

2016 2017
Net sales 54.27M 47.71M 44.41M 40.79M 76.59M 5.2B 77.6M 528M 206M 2.57B 204M 199M 8.88B 106M 93.14M 86.7M 79.62M 150M 10.16B 151M 1.03B 402M 5.02B 398M 389M 17.34B
Net income -103M -90.53M -84.27M -77.39M -145M -9.88B -147M -1B -391M -4.88B -387M -378M -16.85B -125M -110M -102M -94.1M -177M -12.01B -179M -1.22B -476M -5.93B -470M -460M -20.49B
Net Debt 209M 184M 171M 157M 296M 20.09B 300M 2.04B 796M 9.92B 786M 769M 34.29B 246M 216M 201M 185M 347M 23.56B 351M 2.39B 933M 11.63B 922M 902M 40.21B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock